Search - tctmd.com

Displaying 281 - 300 of 657

Sort: Relevancy | Date

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

Todd Neale

November 01, 2019

News Daily News

Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion

Yael L. Maxwell

November 01, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

Presentation TCT 2019

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Medical Therapy Is Best!

Presenter: Freek Verheugt

September 28, 2019

Presentation TCT 2019

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Close the LAA!

Presenter: Kishore Harjai

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Severe DMR and Severe TR

Presenter: Anita Asgar

September 28, 2019

Presentation TCT 2019

Case Viewpoint: Treat Both the MR and TR

Presenter: Neil Fam, MD

September 28, 2019

Presentation TCT 2019

Case Viewpoint: Treat the MR Only

Presenter: Magnus Settergren

September 28, 2019

Presentation TCT 2019

Case Presentation: Severe DMR and Severe TR

Presenter: Anita Asgar

September 28, 2019

Presentation TCT 2019

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Case Viewpoint: Treat the MR; Conservative Management for the AS

Presenter: Brij Maini

September 28, 2019

Presentation TCT 2019

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

Presenter: Rebecca Hahn

September 28, 2019

Presentation TCT 2019

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Presenter: Mohamad Alkhouli

September 27, 2019

Presentation TCT 2019

Utility of CT for Pre-Procedural Planning and Device Selection

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Case-Based Device Selection: Matching the Device With the Anatomy

Presenter: Reda Ibrahim

September 27, 2019

Presentation TCT 2019

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Presenter: George Hanzel

September 27, 2019

Presentation TCT 2019

Optimal Timing for Surveillance Imaging After LAAC

Presenter: Saibal Kar

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Advertisement

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Medical Therapy Is Best!

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Close the LAA!

Case Resolution: How We Treated Severe DMR and Severe TR

Case Viewpoint: Treat Both the MR and TR

Case Viewpoint: Treat the MR Only

Case Presentation: Severe DMR and Severe TR

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Case Viewpoint: Treat the MR; Conservative Management for the AS

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Combined Low-Flow, Low-Gradient Aortic Stenosis and Functional Mitral Regurgitation: A Diagnostic Challenge

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Utility of CT for Pre-Procedural Planning and Device Selection

Case-Based Device Selection: Matching the Device With the Anatomy

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Optimal Timing for Surveillance Imaging After LAAC

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content